Add Yahoo as a preferred source to see more of our stories on Google. A promised cure for sickle cell disease could be revolutionary for populations in Africa, where around 80% of the globe’s cases ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

Tatyana Thompson found a successful experimental treatment for the genetic condition at 30 years old Charna Flam is a writer-reporter at PEOPLE. She has been working at PEOPLE since 2023. Her work has ...

SOUTHFIELD, Mich. – A 24-year-old Southfield college student has become the first patient in Michigan to receive a new gene therapy that could potentially cure sickle cell disease – marking a ...

Summary: Sickle cell disease (SCD) is widely recognized as a blood disorder, but new research reveals its profound impact on the brain’s architecture. Using advanced MRI imaging and analytical tools ...

Sickle cell disease is often thought of solely as a blood disorder, but new research from the Wood Neuro Research Group provides measurable evidence that it can reshape how brain networks function.

HOUSTON, Texas (KTRK) -- Blood donations provide vital support for many patients, especially for those living with sickle cell disease. Sickle cell is an inherited blood disorder that affects the ...

On her best days, Tatyana Thompson’s pain was at a level five. Some days, it would stay that way, a persistent throb in her joints, her hands, her back. On other days, if she was dehydrated or was hit ...

Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine This voice experience is generated by AI. Learn more. This ...

The first gene therapies approved to treat sickle cell disease in December 2023 are struggling on the market. But there are glimpses of forward momentum as Vertex and Genetix Bio provide updates. Just ...

Sickle cell disease (SCD) is the most common genetic haemoglobinopathy worldwide. Due to advancements in care, SCD patients are living longer. Consequently, there is increased interest in long term ...